Lung Cancer Voices Lung Cancer Canada

In today's episode, Dr. Paul Wheatley-Price sits down with Dr. Alain Tremblay, Professor of Medicine and Respirologist at the University of Calgary and Medical Lead of the Alberta Lung Cancer Screening program.

Dr. Tremblay is the winner of the 2023 Geoffrey Ogram Memorial Research Grant for his project on implementing artificial intelligence (AI) to interpret lung cancer screening examinations for better accuracy of readings and to improve efficiency in the patient pathway.

Applications for the 2024 Geoffrey Ogram Memorial Research Grant are now open! Learn more about the grant opportunity at bit.ly/GOMRG

In this episode, Dr. Paul Wheatley-Price sits down with Nina Snyder, Chief Operations Officer at Alberta Lung. Nina introduces Alberta Lung as an organization and what they do to support Albertans living with lung disease, factors like radon and air quality that may lead to a lung cancer diagnosis, challenges like isolation, youth vaping and e-cigarettes, and how lung cancer screening is shaping up across the province. Check out Alberta Lung at www.ablung.ca

We also did a collaboration with Alberta Lung's The Unsung Lung Podcast, where Dr. Paul Wheatley-Price and Dr. Quincy Chu spoke about how the Lung Cancer Voices podcast came to be, new treatments in lung cancer, and what drew them to pursue a career in oncology. Check out their podcast at https://jsperlingg4.podbean.com/e/the-c-word/

In this episode, Dr. Paul Wheatley-Price sits down with Dr Rosalyn Juergens, Medical Oncologist at the Juravinski Cancer Center in Hamilton, ON and Chair of LCC's Medical Advisory Committee.

Dr. Juergens is one of the winners of the Quality Improvement Grant aimed at elevating the care and outcomes of Canadians living with metastatic NSCLC. She chats about her ambitious research proposal focusing on opportunities for liquid vs. solid tissue biopsies in community hospitals in Central-West Ontario, and the inequities and barriers that patients in rural communities face in healthcare and in turn leading to delayed diagnosis.

The grant is offered in collaboration between Lung Cancer Canada, the Lung Health Foundation, the Quebec Lung Association, and Pfizer Canada, with up to $200,000 to be awarded.

For more information, please visit https://www.pfizer.ca/en/media-centre/the-lung-health-foundation-lung-cancer-canada-the-quebec-lung-association-and-pfizer-canada-announce-recipients-of-the-2023-national-quality-improvement-grant-program-to-support-canadians-living-with-lung-cancer

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Amir Safavi, final-year Radiation Oncology Resident at the University of Toronto, and Dr. Jillian Tsai, Staff Radiation Oncologist at Princess Margaret Cancer Centre. They preface the chat with radiation 101, describe what "oligo-" means in the context of oligoradiation, oligometastises & oligoprogression, the possibility of combining oligoradiation with other cancer treatments, and finally, the CURB research study they're working on to test whether they could use stereotactic radiotherapy to stop oligoprogression.

In this episode, Dr. Paul Wheatley-Price speaks to the team of The Palliative Care Early and Systematic (PaCES) Project out of the University of Calgary: Dr. Jessica Simon, Associate Professor and Head of the Division of Palliative Medicine; Lisa Shirt, RN, Clinical Nurse Specialist; and Tim Monds, stage 4 lung cancer survivor.

What is the PaCES project, the benefits of early palliative care for lung cancer patients, and are there plans to get this project going outside of Alberta?

Learn more about the PaCES program at https://cumming.ucalgary.ca/research/paces-project

In the second episode of our "Research in Canada" series, Dr. Paul Wheatley-Price meets with Dr. Enam Alsrayheen, Health Outcomes Scientist at Cape Breton Regional Hospital, who is a recipient of the 2023 Geoffrey Ogram Memorial Research Grant. Dr. Alsrayheen speaks about her research implementing a community lung clinic in the rural areas of Cape Breton, and the accessibility barriers these resolve for Canadians.